Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.

Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E; European Concerted Action on Viral Hepatitis (EUROHEP).

Am J Gastroenterol. 2002 Nov;97(11):2886-95.

PMID:
12425564
2.

Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.

Chen DS.

Princess Takamatsu Symp. 1995;25:27-32. Review.

PMID:
8875606
3.

Chronic hepatitis B virus infection in Asian countries.

Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.

J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. Review.

PMID:
11197043
4.

Natural history of chronic hepatitis B REVEALed.

Chen CJ, Yang HI.

J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. Review.

PMID:
21323729
5.

Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Fattovich G, Stroffolini T, Zagni I, Donato F.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50. Review.

PMID:
15508101
6.

Natural history of hepatitis B.

Marcellin P, Castelnau C, Martinot-Peignoux M, Boyer N.

Minerva Gastroenterol Dietol. 2005 Mar;51(1):63-75. Review.

PMID:
15756147
7.
8.

Molecular mechanism of hepatocarcinogenesis.

Sheu JC.

J Gastroenterol Hepatol. 1997 Oct;12(9-10):S309-13. Review.

PMID:
9407351
9.

Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma.

Caselmann WH, Alt M.

J Hepatol. 1996;24(2 Suppl):61-6. Review.

PMID:
8836891
10.

[Co-infection of HBV with HCV and a possible role of HBV DNA in hepatocarcinogenesis].

Koike K.

Nihon Rinsho. 1999 Jan;57(1):213-9. Review. Japanese.

PMID:
10036965
11.

Hepatitis B and C viruses in hepatitis B surface antigen negative hepatocellular carcinoma patients.

Bréchot C, Minami M, De Mitri S, Paterlini P.

Princess Takamatsu Symp. 1995;25:199-209. Review.

PMID:
8875625
12.

[Hepatocellular carcinoma, hepatitis B virus and the immune system].

Grob PJ.

Schweiz Med Wochenschr. 1986 Aug 23;116(34):1133-45. Review. German.

PMID:
3020684
13.

Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection.

Baffis V, Shrier I, Sherker AH, Szilagyi A.

Ann Intern Med. 1999 Nov 2;131(9):696-701. Review.

PMID:
10577333
14.

What can we learn from hepatitis B virus clinical cohorts?

Lin CL, Tseng TC, Kao JH.

Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716. Review.

PMID:
25529093
15.

Association of hepatitis C virus and hepatocellular carcinoma in the United States.

Reid AE, Liang TJ.

Princess Takamatsu Symp. 1995;25:41-9. Review.

PMID:
8875608
16.

Natural history of chronic hepatitis B and C.

Imperial JC.

J Gastroenterol Hepatol. 1999 May;14 Suppl:S1-5. Review.

PMID:
10382630
17.

Prevention of hepatitis B and C virus infection for prevention of cirrhosis and hepatocellular carcinoma.

Sung JL.

J Gastroenterol Hepatol. 1997 Oct;12(9-10):S370-6. Review.

PMID:
9407359
18.

Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.

Idilman R, De Maria N, Colantoni A, Van Thiel DH.

J Viral Hepat. 1998 Sep;5(5):285-99. Review.

PMID:
9795912
19.

Hepatitis C and hepatitis B-related mortality in Spain.

García-Fulgueiras A, García-Pina R, Morant C, García-Ortuzar V, Génova R, Alvarez E.

Eur J Gastroenterol Hepatol. 2009 Aug;21(8):895-901. doi: 10.1097/MEG.0b013e328313139d. Review.

PMID:
19357523
20.

[Type C hepatitis and hepatocellular carcinoma].

Kobayashi K.

Gan To Kagaku Ryoho. 1992 Oct;19(12):1947-52. Review. Japanese.

PMID:
1329669

Supplemental Content

Support Center